Nektar Therapeutics reported $904.97M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
ALKERMES ALKS:US $ 1097.9M 46.75M
Amgen AMGN:US $ 8247M 1087M
Astrazeneca AZN:US $ 15676M 1246M
Baxter International BAX:US $ 8494M 42M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Biogen BIIB:US $ 10751.9M 69.7M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Eisai 4523:JP Y 722552M 19369M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Exelixis EXEL:US $ 2043.08M 131.89M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Immunogen IMGN:US $ 68.46M 25.66M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Ironwood Pharmaceuticals IRWD:US $ 511.76M 401.56M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Macrogenics MGNX:US $ 319.04M 31.49M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NOVN:VX SF 54042M 3519M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Takeda 4502:JP Y 5299774M 126737M
Teva Pharmaceutical TEVA:IT 10.32B 324M
Xencor XNCR:US $ 646.94M 63.33M
YTE INCY:US $ 2935.86M 208.02M